A Danish PhD student discovers a mechanism in bacteria, which provides new insight into antibiotic resistance.
The Danish research center, Steno Diabetes Center, is partnering in a European research project aimed at improving treatment of non-alcoholic fatty liver disease.
Morten Elbæk Petersen, CEO of the Danish public eHealth portal, sundhed.dk, receives the HIMSS Europe eHealth Leadership Award 2015 presented at eHealth Week in Riga, Latvia.
The new hospital construction in Nykøbing Falster has obtained a DGNB pre-certification for sustainable construction.
Two Danes are featured on FierceBiotech’s list of the world’s most influential people in biotech.
Denmark has the most advanced use of e-health and offers the best market conditions for mobile health business, according to the 2015 edition of the EU Countries’ mHealth App Market Ranking.
Denmark’s first public-private partnership nursing home is now a reality.
Denmark ranks second in the 2015 Innovation Union Scoreboard from the European Union.
The American biopharmaceutical giant, Gilead, acquires Danish biotech comany, EpiTherapeutics ApS, for €59.5 million ($65 million).
With the establishment of a new bio bank, Danish Regions hope to offer treatments with individually tailored biologic response modifiers for rheumatoid arthritis patients.